ChemPartner PharmaTech Co

ChemPartner PharmaTech Co Financial Leverage

The Financial Leverage (Equity Multiplier) of ChemPartner PharmaTech Co (300149.SZ) as of Oct 28, 2026 is 1.59. In the previous year, Financial Leverage (Equity Multiplier) was 1.64 — a change of -3.10% (lower).

Financial Leverage

1.59

YoY

-3.10%

Last updated:

Financial Leverage (Equity Multiplier) of ChemPartner PharmaTech Co is 2025 1.59 . Financial Leverage (Equity Multiplier) of ChemPartner PharmaTech Co was 2024 1.64 . It decreases by -3.10% lower compared to the previous year.

The ChemPartner PharmaTech Co Financial Leverage history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Financial Leverage
Date
Financial Leverage
Jan 1, 2018
1.53 CNY
Jan 1, 2019
1.64 CNY
Jan 1, 2020
1.70 CNY
Jan 1, 2021
2.15 CNY
Jan 1, 2022
1.62 CNY
Jan 1, 2023
1.69 CNY
Jan 1, 2024
1.64 CNY
Jan 1, 2025
1.59 CNY
The ChemPartner PharmaTech Co Financial Leverage history
YEARFinancial LeverageYoY
1.59-3.10%
1.64-2.97%
1.69+4.64%
1.62-24.58%
2.15+26.47%
1.70+3.26%
1.64+7.54%
1.53+18.92%
1.29+24.76%
1.03-1.37%
1.04-4.83%
1.10—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

ChemPartner PharmaTech Co Stock analysis

What does ChemPartner PharmaTech Co do? ChemPartner PharmaTech Co., Ltd. generates revenue through the research, development, production, and sale of prebiotic products, primarily fructooligosaccharides and galactooligosaccharides. The company markets its products under the brand names FOS and GOS, targeting the nutrition and health, dairy, beverage, bakery, and functional snack food industries. Domestic distribution dominates, with South China as the core market, serving manufacturers of food and health products. The firm's product portfolio focuses on fructooligosaccharides and galactooligosaccharides, sold as FOS and GOS, which are integrated into various consumer goods. These prebiotics are essential ingredients in dairy, beverages, baked goods, and functional snacks, meeting demand from food producers seeking health-enhancing additives. South China remains the primary sales region, aligning with the company's domestic market strategy. ChemPartner PharmaTech's revenue streams derive from B2B sales to food and beverage manufacturers, particularly those producing nutrition and health products, dairy, and functional snacks. The company's brands FOS and GOS are positioned as key ingredients for health-focused consumer goods, with sales concentrated in South China, the main market for its domestic distribution network. ChemPartner PharmaTech Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about ChemPartner PharmaTech Co stock

Financial Leverage (Equity Multiplier) of ChemPartner PharmaTech Co is 1.59 in 2025.

Financial Leverage (Equity Multiplier) of ChemPartner PharmaTech Co changed from 1.64 to 1.59, representing a -3.10% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Financial Leverage (Equity Multiplier) ChemPartner PharmaTech Co since 2006 – with annual values, charts, and detailed analysis.

Financial leverage, also known as the equity multiplier, measures total assets relative to equity. Higher leverage amplifies both returns and risks.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Financial Leverage (Equity Multiplier)'s ChemPartner PharmaTech Co with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — ChemPartner PharmaTech Co

All Key Metrics — ChemPartner PharmaTech Co